{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:51:10Z","timestamp":1778053870442,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109216","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:40:08Z","timestamp":1731915608000},"page":"109216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah Health"],"prefix":"10.1016","volume":"245","author":[{"given":"Hailey L.","family":"Vandenhazel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara R.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.thromres.2024.109216_bb0005","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2024.109216_bb0010","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.thromres.2024.109216_bb0015","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.thromres.2024.109216_bb0020","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Schunemann","year":"2018","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2024.109216_bb0025","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.thromres.2024.109216_bb0030","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2024.109216_bb0035","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH","volume":"14","author":"Martin","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2024.109216_bb0040","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC subcommittee on control of anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109216_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11239-020-02179-4","article-title":"Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis","volume":"51","author":"Elshafei","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"9","key":"10.1016\/j.thromres.2024.109216_bb0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.amjmed.2017.05.011","article-title":"Influences of obesity and bariatric surgery on the clinical and pharmacologic profile of rivaroxaban","volume":"130","author":"Moore","year":"2017","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2024.109216_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1060028019886092","article-title":"Rivaroxaban versus warfarin for stroke prevention and venous thromboembolism treatment in extreme obesity and high body weight","volume":"54","author":"Perales","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.thromres.2024.109216_bb0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjmed.2023.01.010","article-title":"Direct oral anticoagulants in obese patients with venous thromboembolism: results of an expert consensus panel","volume":"136","author":"Rosovsky","year":"2023","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2024.109216_bb0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1060028020923584","article-title":"Direct Oral anticoagulants in obesity: an updated literature review","volume":"54","author":"Sebaaly","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.thromres.2024.109216_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2044","article-title":"Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: a systematic review and meta-analysis","volume":"7","author":"Adelkhanova","year":"2024","journal-title":"Health Sci Rep"},{"issue":"5","key":"10.1016\/j.thromres.2024.109216_bb0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1358863X241264478","article-title":"Comparing DOAC and warfarin outcomes in an obese population using the \u2018real-world\u2019 Michigan anticoagulation quality improvement initiative (MAQI(2)) registry","volume":"29","author":"Ardeshna","year":"2024","journal-title":"Vasc. Med."},{"key":"10.1016\/j.thromres.2024.109216_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.08.009","article-title":"Treatment of atrial fibrillation and venous thromboembolism with factor Xa inhibitors in severely obese patients","author":"Dobry","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.thromres.2024.109216_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133784","article-title":"Efficacy and safety of direct Oral anticoagulants versus warfarin in obese patients (BMI >\/= 30 kg\/m(2)) with atrial fibrillation or venous thromboembolism: an updated systematic review and meta-analysis","volume":"13","author":"Karakasis","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2024.109216_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2023.09.001","article-title":"Safety and efficacy of oral anticoagulants in extreme weights","volume":"231","author":"Chin-Hon","year":"2023","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2024.109216_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/phar.2369","article-title":"Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism","volume":"40","author":"Coons","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.thromres.2024.109216_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11239-023-02774-1","article-title":"DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network","volume":"55","author":"Martin","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.thromres.2024.109216_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11239-022-02668-8","article-title":"Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism","volume":"54","author":"Novak","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"issue":"11","key":"10.1016\/j.thromres.2024.109216_bb0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jacc.2019.12.068","article-title":"Select drug-drug interactions with direct oral anticoagulants: JACC review topic of the week","volume":"75","author":"Wiggins","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2024.109216_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107550","article-title":"Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010\u20132018","volume":"113","author":"Acton","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.thromres.2024.109216_bb0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1076029616687849","article-title":"Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants","volume":"24","author":"Clark","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:08Z","timestamp":1735237988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S0049384824003487"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109216","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah Health","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109216"}}